Objective Physiologic Testing to Guide Treatment Adjustments with the TM Flow System
Symptoms and labs do not always show vascular or autonomic change. How TM Flow testing helps clinicians judge whether cardiometabolic treatment is working.
Symptoms and labs do not always show vascular or autonomic change. How TM Flow testing helps clinicians judge whether cardiometabolic treatment is working.
Distinguishing normal aging from early cognitive decline is difficult when symptoms fluctuate. How the COGNISION System documents change with objective data.
How to use TM Flow System results in chronic disease management plans for diabetes, hypertension, dyslipidemia and metabolic syndrome in primary care.
Diabetes, cardiovascular disease and depression affect cognition. How COGNISION testing adds cognitive monitoring to Chronic Care Management programs.
How to add TM Flow vascular and autonomic testing to Annual Wellness Visits to catch silent cardiometabolic changes in diabetes and hypertension.
How the COGNISION System gives primary care objective ERP/EEG data to document cognitive stability, or change, in aging patients over time.
Separating normal aging from evolving impairment is hard at one visit. How the COGNISION System supports longitudinal cognitive monitoring in primary care.
PAD often progresses silently and physical exam alone lacks sensitivity. How the TM Flow System’s ABI testing detects hidden peripheral arterial disease.
Leg numbness, burning or exertional pain can come from small fiber neuropathy or PAD. How TM Flow testing tells them apart in diabetes and metabolic syndrome.
FDA-cleared ERP/EEG testing for clinics: how the COGNISION System gives primary care objective, reproducible cognitive data that questionnaires cannot.